TPST-2206

N/A

Report date: 2025/11/25 17:29:02

Base Information

Drug NameTPST-2206

Drug Alias NameTPST-2206

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionCD70 antigen modulators

TargetsCD70 antigen

Therapy Area/IndicationsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFactor Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesTempest Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsCarcinoma, Renal Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A